M&T Bank
CDNA icon

M&T Bank’s CareDx CDNA Stock Holding History

M&T Bank’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-46,692
Closed -$532K – 1710
2022
Q4 		$532K Buy
46,692
+12,246
+36% +$181K ﹤0.01% 1080
2022
Q3 		$586K Buy
34,446
+4,106
+14% +$88.1K ﹤0.01% 1021
2022
Q2 		$652K Buy
30,340
+8,104
+36% +$225K ﹤0.01% 911
2022
Q1 		$822K Buy
22,236
+14,306
+180% +$558K ﹤0.01% 824
2021
Q4 		$361K Buy
7,930
+3,157
+66% +$165K ﹤0.01% 1162
2021
Q3 		$302K Sell
4,773
-910
-16% -$69.3K ﹤0.01% 1228
2021
Q2 		$520K Hold
5,683
– – ﹤0.01% 1018
2021
Q1 		$387K Sell
5,683
-3,385
-37% -$263K ﹤0.01% 1110
2020
Q4 		$657K Sell
9,068
-4,616
-34% -$267K ﹤0.01% 924
2020
Q3 		$520K Buy
13,684
+3,180
+30% +$107K ﹤0.01% 967
2020
Q2 		$373K Sell
10,504
-742
-7% -$21.1K ﹤0.01% 1089
2020
Q1 		$245K Buy
+11,246
New +$252K ﹤0.01% 1242
2019
Q3 		– Sell
-5,689
Closed -$205K – 1620
2019
Q2 		$205K Sell
5,689
-1,679
-23% -$53.7K ﹤0.01% 1413
2019
Q1 		$232K Buy
+7,368
New +$215K ﹤0.01% 1334
2017
Q1 		– Sell
-17,689
Closed -$48K – 1677
2016
Q4 		$48K Buy
+17,689
New +$61.3K ﹤0.01% 1574

Other funds holding CDNA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

M&T Bank's CDNA Position: Q1 2023 in Review

M&T Bank sold out of CareDx (CDNA) in Q1 2023, closing a stake of 46,692 shares — an estimated $532K sold.

M&T Bank first reported a position in CDNA in Q4 2016 and held it in 15 quarters. The position peaked at $822K in Q1 2022. 156 funds tracked by Wall St. Rank hold CDNA as of Q1 2023.

  • M&T Bank reported no remaining CareDx position as of Q1 2023 after selling out during the quarter.
  • M&T Bank sold 46,692 CareDx shares in Q1 2023, an estimated $532K.
  • M&T Bank first reported a position in CareDx in Q4 2016 and held it in 15 quarters.
  • M&T Bank's CareDx position peaked at $822K in Q1 2022.
  • 156 funds tracked by Wall St. Rank held CareDx as of Q1 2023.

Based on M&T Bank's 13F filing for Q1 2023, filed 11 May 2023.